NCT02716012 2025-03-10
OUTREACH
Mina Alpha Limited
Phase 1 Unknown
Clinical Trials
362 trialsNCT03310632 2024-09-25
Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer
Golden Biotechnology Corporation
Phase 1/2 Unknown
NCT05830097 2024-08-26
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Phase 1/2 Unknown
NCT06256055 2024-07-24
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Phase 1 Unknown
NCT06094777 2024-06-13
A Study of HY-0102 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT06270706 2024-06-12
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Pliant Therapeutics, Inc.
Phase 1 Unknown
NCT05605197 2024-05-28
U87 CART in Treatment of Advanced Solid Tumor
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1 Unknown
NCT05311618 2024-04-01
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
Phase 1 Unknown
NCT05626985 2024-04-01
Refinement and Validation of a Diagnostic Model (GAMAD) for Early Detection of Hepatocellular Carcinoma
Singlera Genomics Inc.
Unknown
NCT05783570 2024-03-15
To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307
Eutilex
Phase 1 Unknown
NCT05872867 2024-03-12
MK-3475-E90
Wellmarker Bio
Phase 1 Unknown
NCT05472857 2024-03-06
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Suzhou Immunofoco Biotechnology Co., Ltd
Phase 1 Unknown
NCT06294873 2024-03-06
Stool Sample Collection Study
Innovis LLC
Unknown
NCT04780217 2024-03-04
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
NCT06075849 2024-02-23
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
Panolos Bioscience
Phase 1 Unknown
NCT05178043 2024-02-22
GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Unknown
NCT04633512 2024-02-21
Safety and Feasibility of ActivSightTM in Human
Activ Surgical
Phase NA Unknown
NCT05591053 2024-02-21
Utility and Usability of ActivSightâ„¢ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans
Activ Surgical
Phase NA Unknown
NCT05632744 2024-02-14
Evaluation of CG-100 Intraluminal Bypass Device
Colospan Ltd.
Phase NA Unknown
NCT06255041 2024-02-12
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
Unknown
NCT04149691 2024-02-07
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Celon Pharma SA
Phase 1 Unknown
NCT05400408 2024-02-07
Cancer
Scentech Medical Technologies Ltd
Phase NA Unknown
NCT05787535 2024-02-02
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
Phase 1 Unknown
NCT04560894 2024-02-01
HCC
Sinocelltech Ltd.
Phase 2/3 Unknown
NCT06010901 2024-01-23
A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT05415475 2024-01-05
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Chongqing Precision Biotech Co., Ltd
Phase 1 Unknown
NCT06178809 2024-01-03
Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma
Singlera Genomics Inc.
Unknown
NCT06144385 2024-01-02
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Phase 1 Unknown
NCT04714190 2023-12-21
A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression
RemeGen Co., Ltd.
Phase 3 Unknown
NCT04329429 2023-12-20
A Study of RC48-ADC in Subjects With HER2 Overexpressed Metastatic Biliary Tract Cancer
RemeGen Co., Ltd.
Phase 2 Unknown
NCT05514158 2023-12-18
To Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Disitamab Vedotin Combined With RC98 in the Treatment of Subjects With HER2-expressing Locally Advanced or Metastatic Gastric Cancer (Including AEG)
RemeGen Co., Ltd.
Phase 1 Unknown
NCT04264702 2023-12-12
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
Natera, Inc.
Unknown
NCT04450732 2023-12-05
Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Phase 1 Unknown
NCT04338763 2023-11-18
RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer
Rise Biopharmaceuticals, Inc.
Phase 1 Unknown
NCT02975661 2023-10-25
Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery
Qidong Gaitianli Medicines Co., Ltd
Unknown
NCT06098898 2023-10-25
Safety and Efficacy of NK510 to Treat Gastric Cancer
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03129139 2023-10-18
Minnelide 101
Minneamrita Therapeutics LLC
Phase 1 Unknown
NCT05566834 2023-10-18
Minnelideâ„¢ Capsules Alone and in Combination With Paclitaxel in Advanced Gastric Cancer
Minneamrita Therapeutics LLC
Phase 1 Unknown
NCT06088459 2023-10-18
NWRD06 DNA Plasmid for HCC After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Phase 1 Unknown
NCT06089330 2023-10-18
A Study of JMT101 in Patients With Metastatic Colorectal Cancer
Shanghai JMT-Bio Inc.
Phase 2 Unknown
NCT06078800 2023-10-12
A Study of YL-17231 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Unknown
NCT03382340 2023-09-28
IMX-110 in Patients With Advanced Solid Tumors
Immix Biopharma, Inc.
Phase 1/2 Unknown
NCT05352646 2023-09-28
NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical Resection
Newish Technology (Beijing) Co., Ltd.
Phase 1 Unknown
NCT06039202 2023-09-15
Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer
Holy Stone Healthcare Co., Ltd
Phase 2 Unknown
NCT03447951 2023-09-13
OASES
Gongwin Biopharm Co., Ltd.
Phase 2 Unknown
NCT05669521 2023-08-14
Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690
Tosk, Inc.
Phase 2 Unknown
NCT05127759 2023-08-08
The Efficacy and Safety of HLX208 in Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation
Shanghai Henlius Biotech
Phase 2 Unknown
NCT05648955 2023-07-28
ALLIES
Nutricia Research
Phase EARLY_PHASE1 Unknown
NCT05965999 2023-07-28
Lucid Registry
PAVmed Inc.
Unknown
NCT04169347 2023-07-27
FOLFOXIRI Plus Panitumumab in Metastatic RAS Wild-type, Left-sided Colorectal Cancer
Criterium, Inc.
Phase 2 Unknown